BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jackson-Cowan L, Eldahshan W, Dumanli S, Dong G, Jamil S, Abdul Y, Althomali W, Baban B, Fagan SC, Ergul A. Delayed Administration of Angiotensin Receptor (AT2R) Agonist C21 Improves Survival and Preserves Sensorimotor Outcomes in Female Diabetic Rats Post-Stroke through Modulation of Microglial Activation. Int J Mol Sci 2021;22:1356. [PMID: 33572986 DOI: 10.3390/ijms22031356] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Shen L, Chen D, Lou Q, Cao P, Hu R, Jin Y, Wang D, Hu S. Angiotensin Type 2 Receptor Pharmacological Agonist Relieves Neurocognitive Deficits via Reducing Neuroinflammation and Microglial Engulfment of Dendritic Spines. J Neuroimmune Pharmacol 2022. [DOI: 10.1007/s11481-022-10054-7] [Reference Citation Analysis]
2 Jiang Y, Liu Z, Liao Y, Sun S, Dai Y, Tang Y. Ischemic stroke: From pathological mechanisms to neuroprotective strategies. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.1013083] [Reference Citation Analysis]
3 Steckelings UM, Widdop RE, Sturrock ED, Lubbe L, Hussain T, Kaschina E, Unger T, Hallberg A, Carey RM, Sumners C. The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target. Pharmacol Rev 2022;74:1051-135. [PMID: 36180112 DOI: 10.1124/pharmrev.120.000281] [Reference Citation Analysis]
4 Fouda AY, Ahmed H, Pillai B, Kozak A, Hardigan T, Ergul A, Fagan SC, Ishrat T. Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke. Neurochemistry International 2022. [DOI: 10.1016/j.neuint.2022.105375] [Reference Citation Analysis]
5 Pantea I, Repanovici A, Cocuz ME. Analysis of Research Directions on the Rehabilitation of Patients with Stroke and Diabetes Using Scientometric Methods. Healthcare 2022;10:773. [DOI: 10.3390/healthcare10050773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Annoni F, Moro F, Caruso E, Zoerle T, Taccone FS, Zanier ER. Angiotensin-(1-7) as a Potential Therapeutic Strategy for Delayed Cerebral Ischemia in Subarachnoid Hemorrhage. Front Immunol 2022;13:841692. [PMID: 35355989 DOI: 10.3389/fimmu.2022.841692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jurcau A, Simion A. Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies. Int J Mol Sci 2021;23:14. [PMID: 35008440 DOI: 10.3390/ijms23010014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 16.0] [Reference Citation Analysis]
8 Lin M, Roth RA, Kozel BA, Mecham RP, Halabi CM. Loss of Angiotensin II Type 2 Receptor Improves Blood Pressure in Elastin Insufficiency. Front Cardiovasc Med 2021;8:782138. [PMID: 34790711 DOI: 10.3389/fcvm.2021.782138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bahader GA, Nash KM, Almarghalani DA, Alhadidi Q, McInerney MF, Shah ZA. Type-I diabetes aggravates post-hemorrhagic stroke cognitive impairment by augmenting oxidative stress and neuroinflammation in mice. Neurochem Int 2021;149:105151. [PMID: 34348124 DOI: 10.1016/j.neuint.2021.105151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]